Lotus Tissue Repair Inc. has raised $26 million in a Series A round led by Third Rock Ventures. The company is developing technology to be used in the treatment of dystrophic epidermolysis bullosa. Read More
AEGEA Medical Inc., which is developing a minimally invasive treatment for abnormal uterine bleeding, has sealed $13.3 million in new financing led by Covidien Ventures. Read More
Semprius raised $20 million in a first tranche of a Series C round. Siemens Venture Capital led the investment round in the solar module maker. Read More
